• $600m are invested in academic research in quebec every year.

• BRCA 1 and 2 genes for breast and ovarian cancer risk identification…

• medical castration with GnRH agonists for the treatment of prostate cancer…

• in vitro maturation of ovocytes for better in vitro fertilisation…

• DNA-based rapid bacterial diagnosis for faster treatment…

…Ground-breaking discoveries, made right here in Quebec.

1 Westmount Square, Suite 800
Montreal, Quebec
H3Z 2P9

T 514-849-7696
F 514-849-5191

This is a list of the projects financed by AmorChem. Please contact us for further information.


Titanium Foam Compression Screw – orthopedics – Dr. Paul Martineau, Dr. Ed Harvey and Louis-Philippe Lefebvre
DNMTI – oncology - Dr. Richard Daifuku
RNA foci disruption – myotonic dystrophy – Dr. Pascal Chartrand
S100A9 – inflammation- InflammatoRx , Dr. Philippe Tessier
Diagnostic/Prognostic/Therapeutic tools– Acute myeloid leukemia – Dr. Guy Sauvageau and Dr. Josée Hébert
Frataxin – Friedreich's ataxia – Dr. Jacques P. Tremblay
Greater Trochanter fixation system – orthopedics – Dr. Yvan Petit and Dr. Yves Laflamme
Mucoadhesive nanotechnology platform – ophthalmology – Dr. Frank Gu
GvHD prognostic tool – Dr. Claude Perreault, Dr. Denis-Claude Roy and Dr. Silvy Lachance


MPERIA THERAPEUTICS INC. (CD36 – dry AMD and cardiovascular diseases – Dr. Huy Ong)
EOSINATE INC. (5-OXO-ETE – asthma/eosinophilic diseases – Dr. Bill Powell and Dr. Joe Rokach)
SPECIFICIT PHARMA (T-cell based treatment using MiHAs – Dr. Claude Perreault and Dr. Denis-Claude Roy)
CORBIN THERAPEUTICS (DUB – neuroinflammation – Dr. Philippe Gros)
SEMATHERA (SEMA3a diabetic macular oedema - Dr. Przemlyslaw (Mike) Sapieha)


DM1 – Myotonic Dystrophy Type 2 – Dr. Pascal Chartrand COLLABORATION WITH ROCHE
CFTR – Cystic fibrosis - Traffick Therapeutic, Dr. John Hanrahan and Dr. David Thomas SOLD TO VERTEX
About UsProcessPortfolioOur TeamNewsNuChemContactFrançais

© 2019 AmorChem. All rights reserved. Developed by Grafika Designs a Montreal Web Design company.